LIU Man, LIU Liyun, SUN Fan, LIN Houwen. The discovery of antitumor compounds from marine sponge targeting lung cancer stem cells[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 304-307. doi: 10.3969/j.issn.1006-0111.2017.04.005
Citation:
|
LIU Man, LIU Liyun, SUN Fan, LIN Houwen. The discovery of antitumor compounds from marine sponge targeting lung cancer stem cells[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 304-307. doi: 10.3969/j.issn.1006-0111.2017.04.005
|
The discovery of antitumor compounds from marine sponge targeting lung cancer stem cells
-
Department of Pharmacy, Renji Hospital Affiliated to School of Medicine, Shanghai JiaoTong University, Shanghai 200127, China
- Received Date: 2017-03-28
- Rev Recd Date:
2017-05-10
-
Abstract
Objective To screen the active compounds targeting lung cancer stem cells (LCSCs) from the sponge Aaptos aaptos. Methods The A549-Nanog-GFP model of LCSCs was constructed. Western blot and immunofluorescence were used to examine the expression of pluripotency markers in screening model. The established LCSCs model was used to screen 8 fractions of Aaptos aaptos dichloromethane extract. The active fraction was separated by various chromatographic methods. CCK8 assay was used to screen the compounds for anti-LCSCs activity in vitro. Results LCSCs model with high expression of CD44 and ALDH1A1 protein was successfully constructed. The fraction D6 showed significant inhibitory activity in LCSCs(P<0.01). Four aaptamine alkaloids were isolated from this fraction. Compound AP-1 has good activity against LCSCs(P<0.01)with IC50 value(3.84±0.12) μmol/L. Conclusion AP-1 isolated from the sponge Aaptos aaptos exhibited significant activity against LCSCs.
-
References
[1]
|
Kaiser J. The cancer stem cell gamble[J]. Science, 2015, 347 (6219): 226-229. |
[2]
|
Beck B, Blanpain C. Unravelling cancer stem cell potential[J]. Nat Rev Cancer, 2013, 13 (10): 727-738. |
[3]
|
Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer[J]. Cell, 2005, 121 (6): 823-835. |
[4]
|
Barr MP, Gray SG, Hoffmann AC, et al. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature[J]. PloS ONE,2013, 8 (1): e54193. |
[5]
|
Nishi M, Akutsu H, Kudoh A, et al. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell[J]. Oncotarget, 2014, 5 (18): 8665-8680. |
[6]
|
Chiou SH, Wang ML, Chou YT, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation[J]. Cancer Res,2010, 70 (24): 10433-10444. |
[7]
|
Roue M, Quevrain E, Domart-Coulon I, et al. Assessing calcareous sponges and their associated bacteria for the discovery of new bioactive natural products[J]. Nat Prod Rep, 2012, 29 (7): 739-751. |
[8]
|
Martins A, Vieira H, Gaspar H, et al. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success[J]. Marine Drugs, 2014, 12 (2): 1066-1101. |
[9]
|
Glaser KB, Mayer AM. A renaissance in marine pharmacology: from preclinical curiosity to clinical reality[J]. Biochem Pharmacol, 2009, 78 (5): 440-448. |
[10]
|
Ottinger S, Kloppel A, Rausch V, et al. Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract[J]. Int J Cancer, 2012, 130 (7): 1671-1681. |
[11]
|
Deshmukh A, Deshpande K, Arfuso F, et al. Cancer stem cell metabolism: a potential target for cancer therapy[J]. Mol Cancer,2016, 15 (1): 69. |
-
-
Proportional views
-